Gutierrez-Sandoval, R.; Gutiérrez-Castro, F.; Muñoz-Godoy, N.; Rivadeneira, I.; Sobarzo, A.; Iturra, J.; Krakowiak, F.; Alarcón, L.; Dorado, W.; Lagos, A.;
et al. Beyond Exosomes: An Ultrapurified Phospholipoproteic Complex (PLPC) as a Scalable Immunomodulatory Platform for Reprogramming Immune Suppression in Metastatic Cancer. Cancers 2025, 17, 1658.
https://doi.org/10.3390/cancers17101658
AMA Style
Gutierrez-Sandoval R, Gutiérrez-Castro F, Muñoz-Godoy N, Rivadeneira I, Sobarzo A, Iturra J, Krakowiak F, Alarcón L, Dorado W, Lagos A,
et al. Beyond Exosomes: An Ultrapurified Phospholipoproteic Complex (PLPC) as a Scalable Immunomodulatory Platform for Reprogramming Immune Suppression in Metastatic Cancer. Cancers. 2025; 17(10):1658.
https://doi.org/10.3390/cancers17101658
Chicago/Turabian Style
Gutierrez-Sandoval, Ramon, Francisco Gutiérrez-Castro, Natalia Muñoz-Godoy, Ider Rivadeneira, Adolay Sobarzo, Jordan Iturra, Francisco Krakowiak, Luis Alarcón, Wilson Dorado, Andy Lagos,
and et al. 2025. "Beyond Exosomes: An Ultrapurified Phospholipoproteic Complex (PLPC) as a Scalable Immunomodulatory Platform for Reprogramming Immune Suppression in Metastatic Cancer" Cancers 17, no. 10: 1658.
https://doi.org/10.3390/cancers17101658
APA Style
Gutierrez-Sandoval, R., Gutiérrez-Castro, F., Muñoz-Godoy, N., Rivadeneira, I., Sobarzo, A., Iturra, J., Krakowiak, F., Alarcón, L., Dorado, W., Lagos, A., Montenegro, D., Muñoz, I., Aguilera, R., & Toledo, A.
(2025). Beyond Exosomes: An Ultrapurified Phospholipoproteic Complex (PLPC) as a Scalable Immunomodulatory Platform for Reprogramming Immune Suppression in Metastatic Cancer. Cancers, 17(10), 1658.
https://doi.org/10.3390/cancers17101658